Ptc Therapeutics (PTCT) Other Operating Expenses (2017 - 2025)
Historic Other Operating Expenses for Ptc Therapeutics (PTCT) over the last 11 years, with Q1 2025 value amounting to $800000.0.
- Ptc Therapeutics' Other Operating Expenses rose 70000.0% to $800000.0 in Q1 2025 from the same period last year, while for Sep 2025 it was $11.0 million, marking a year-over-year increase of 46583.33%. This contributed to the annual value of $4.5 million for FY2024, which is 9649.57% down from last year.
- Latest data reveals that Ptc Therapeutics reported Other Operating Expenses of $800000.0 as of Q1 2025, which was up 70000.0% from $10.2 million recorded in Q4 2024.
- In the past 5 years, Ptc Therapeutics' Other Operating Expenses registered a high of $128.9 million during Q2 2023, and its lowest value of -$10.8 million during Q3 2021.
- For the 5-year period, Ptc Therapeutics' Other Operating Expenses averaged around $9.4 million, with its median value being $100000.0 (2024).
- Within the past 5 years, the most significant YoY rise in Ptc Therapeutics' Other Operating Expenses was 1180000.0% (2022), while the steepest drop was 15206.61% (2022).
- Ptc Therapeutics' Other Operating Expenses (Quarter) stood at $12.1 million in 2021, then plummeted by 152.07% to -$6.3 million in 2022, then soared by 142.86% to $2.7 million in 2023, then skyrocketed by 276.85% to $10.2 million in 2024, then tumbled by 92.14% to $800000.0 in 2025.
- Its Other Operating Expenses stands at $800000.0 for Q1 2025, versus $10.2 million for Q4 2024 and -$700000.0 for Q3 2024.